LEMAITRE VASCULAR INC's ticker is LMAT and the CUSIP is 525558201. A total of 181 filers reported holding LEMAITRE VASCULAR INC in Q2 2022. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,249,206 | +50.6% | 27,336 | +21.5% | 0.01% | +60.0% |
| Q1 2024 | $1,493,432 | +50.0% | 22,505 | +28.3% | 0.01% | +25.0% |
| Q4 2023 | $995,854 | -16.3% | 17,545 | -19.6% | 0.00% | -20.0% |
| Q3 2023 | $1,189,571 | -8.8% | 21,835 | +12.6% | 0.01% | 0.0% |
| Q2 2023 | $1,304,761 | +273.9% | 19,393 | +158.6% | 0.01% | +400.0% |
| Q1 2022 | $349,000 | -7.4% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $377,000 | -5.3% | 7,500 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $398,000 | -20.1% | 7,500 | -8.1% | 0.00% | 0.0% |
| Q2 2021 | $498,000 | +21.2% | 8,160 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $411,000 | +13.5% | 8,430 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $362,000 | +5.5% | 8,930 | -15.4% | 0.00% | 0.0% |
| Q3 2020 | $343,000 | -20.6% | 10,550 | -35.6% | 0.00% | 0.0% |
| Q2 2020 | $432,000 | +52.1% | 16,370 | +43.4% | 0.00% | 0.0% |
| Q1 2020 | $284,000 | – | 11,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 350,194 | $11,724,000 | 1.96% |
| Ranger Investment Management | 699,843 | $23,431,000 | 1.64% |
| THB ASSET MANAGEMENT | 392,100 | $13,127,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 64,550 | $2,161,000 | 1.55% |
| Conestoga Capital Advisors, LLC | 1,392,591 | $46,624,000 | 1.50% |
| Summit Creek Advisors LLC | 213,761 | $7,157,000 | 1.28% |
| Biondo Investment Advisors, LLC | 107,405 | $3,603,000 | 0.91% |
| Concorde Asset Management, LLC | 21,207 | $710,000 | 0.81% |
| Capital Impact Advisors, LLC | 51,542 | $1,739,000 | 0.64% |
| Sapphire Star Partners LP | 12,290 | $412,000 | 0.42% |